{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T18:04:33Z","timestamp":1780077873638,"version":"3.54.0"},"reference-count":44,"publisher":"The Endocrine Society","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2007,8,1]]},"abstract":"<jats:p>The renin-angiotensin-aldosterone system contributes to cardiac remodeling, hypertrophy, and left ventricular dysfunction. Angiotensin II and aldosterone (corticosterone in rodents) together generate reactive oxygen species (ROS) via reduced nicotinamide adenine dinucleotide phosphate (NADPH) oxidase, which likely facilitate this hypertrophy and remodeling. This investigation sought to determine whether cardiac oxidative stress and cellular remodeling could be attenuated by in vivo mineralocorticoid receptor (MR) blockade in a rodent model of the chronically elevated tissue renin-angiotensin-aldosterone system, the transgenic TG (mRen2) 27 rat (Ren2). The Ren2 overexpresses the mouse renin transgene with resultant hypertension, insulin resistance, proteinuria, and cardiovascular damage. Young (6- to 7-wk-old) male Ren2 and age-matched Sprague-Dawley rats were treated with spironolactone or placebo for 3 wk. Heart tissue ROS, immunohistochemical analysis of 3-nitrotyrosine, and NADPH oxidase (NOX) subunits (gp91phox recently renamed NOX2, p22phox, Rac1, NOX1, and NOX4) were measured. Structural changes were assessed with cine-magnetic resonance imaging, transmission electron microscopy, and light microscopy. Significant increases in Ren2 septal wall thickness (cine-magnetic resonance imaging) were accompanied by perivascular fibrosis, increased mitochondria, and other ultrastructural changes visible by light microscopy and transmission electron microscopy. Although there was no significant reduction in systolic blood pressure, significant improvements were seen with MR blockade on ROS formation and NOX subunits (each P &amp;lt; 0.05). Collectively, these data suggest that MR blockade, independent of systolic blood pressure reduction, improves cardiac oxidative stress-induced structural and functional changes, which are driven, in part, by angiotensin type 1 receptor-mediated increases in NOX.<\/jats:p>","DOI":"10.1210\/en.2006-1691","type":"journal-article","created":{"date-parts":[[2007,5,11]],"date-time":"2007-05-11T00:49:24Z","timestamp":1178844564000},"page":"3773-3780","source":"Crossref","is-referenced-by-count":88,"title":["Mineralocorticoid Receptor Blockade Attenuates Chronic Overexpression of the Renin-Angiotensin-Aldosterone System Stimulation of Reduced Nicotinamide Adenine Dinucleotide Phosphate Oxidase and Cardiac Remodeling"],"prefix":"10.1210","volume":"148","author":[{"given":"Sameer","family":"Stas","sequence":"first","affiliation":[{"name":"Divisions of Endocrinology (S.S., M.R.H., J.R.S.) Columbia, Missouri 65212"},{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Whaley-Connell","sequence":"additional","affiliation":[{"name":"Nephrology (A.W.-C.) Columbia, Missouri 65212"},{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"},{"name":"Harry S. Truman Veterans Administration Medical Center (A.W.-C., J.H., L.A., J.R.S.), Columbia, Missouri 65201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javad","family":"Habibi","sequence":"additional","affiliation":[{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"},{"name":"Harry S. Truman Veterans Administration Medical Center (A.W.-C., J.H., L.A., J.R.S.), Columbia, Missouri 65201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Appesh","sequence":"additional","affiliation":[{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"},{"name":"Harry S. Truman Veterans Administration Medical Center (A.W.-C., J.H., L.A., J.R.S.), Columbia, Missouri 65201"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin R.","family":"Hayden","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology (S.S., M.R.H., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Poorna R.","family":"Karuparthi","sequence":"additional","affiliation":[{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mahnaz","family":"Qazi","sequence":"additional","affiliation":[{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E. Matthew","family":"Morris","sequence":"additional","affiliation":[{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shawna A.","family":"Cooper","sequence":"additional","affiliation":[{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C. Daniel","family":"Link","sequence":"additional","affiliation":[{"name":"Department of Medicine (C.S., C.D.L), The University of Arizona, Tucson, Arizona 85721"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Stump","sequence":"additional","affiliation":[{"name":"Department of Medicine (C.S., C.D.L), The University of Arizona, Tucson, Arizona 85721"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith","family":"Hay","sequence":"additional","affiliation":[{"name":"University of Iowa (M.H.), Iowa City, Iowa 52242"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Ferrario","sequence":"additional","affiliation":[{"name":"Wake Forest University School of Medicine (C.F.), Winston-Salem, North Carolina 27157"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James R.","family":"Sowers","sequence":"additional","affiliation":[{"name":"Divisions of Endocrinology (S.S., M.R.H., J.R.S.) Columbia, Missouri 65212"},{"name":"Diabetes and Cardiovascular Lab (S.S., A.W.-C., J.H., L.A., M.Q., E.M.M., S.A.C., J.R.S.) Columbia, Missouri 65212"},{"name":"University of Missouri School of Medicine (S.S., A.W.-C., J.H., L.A., M.R.H., P.R.K., M.Q., E.M.M., S.A.C., J.R.S.), Columbia, Missouri 65212"},{"name":"Harry S. Truman Veterans Administration Medical Center (A.W.-C., J.H., L.A., J.R.S.), Columbia, Missouri 65201"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"80","reference":[{"key":"2020071613313463000_R1","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1006\/jmcc.1994.1098","article-title":"Collagen metabolism in cultured adult rat cardiac fibroblasts: response to angiotensin II and aldosterone.","volume":"26","author":"Brilla","year":"1994","journal-title":"J Mol Cell Cardiol"},{"key":"2020071613313463000_R2","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1046\/j.1440-1681.2001.03586.x","article-title":"Mineralocorticoids and cardiac fibrosis: the decade in review.","volume":"28","author":"Funder","year":"2001","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"2020071613313463000_R3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1161\/01.HYP.0000023182.68420.EB","article-title":"Excess aldosterone is associated with alterations of myocardial texture in primary aldosteronism.","volume":"40","author":"Rossi","year":"2002","journal-title":"Hypertension"},{"key":"2020071613313463000_R4","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613313463000_R5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0002-9440(10)64454-9","article-title":"Aldosterone-induced inflammation in the rat heart: role of oxidative stress.","volume":"161","author":"Sun","year":"2002","journal-title":"Am J Pathol"},{"key":"2020071613313463000_R6","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1161\/01.HYP.0000203732.03784.3b","article-title":"Mineralocorticoid receptors and cardiovascular damage: it\u2019s not just aldosterone.","volume":"47","author":"Funder","year":"2006","journal-title":"Hypertension"},{"key":"2020071613313463000_R7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1161\/01.RES.71.3.503","article-title":"Immunohistochemical and biochemical evidence for a cardiovascular mineralocorticoid receptor.","volume":"71","author":"Lombes","year":"1992","journal-title":"Circ Res"},{"key":"2020071613313463000_R8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/endo.143.1.8583","article-title":"11\u03b2-hydroxysteroid dehydrogenase 1 transforms 11-dehydrocorticosterone into transcriptionally active glucocorticoid in neonatal rat heart.","volume":"143","author":"Sheppard","year":"2002","journal-title":"Endocrinology"},{"key":"2020071613313463000_R9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1161\/01.RES.0000080521.15238.E5","article-title":"Transgenic model of aldosterone-driven cardiac hypertrophy and heart failure.","volume":"93","author":"Qin","year":"2003","journal-title":"Circ Res"},{"key":"2020071613313463000_R10","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy.","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"2020071613313463000_R11","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/01.HYP.33.4.981","article-title":"Angiotensin AT1 receptor subtype as a cardiac target of aldosterone.","volume":"33","author":"Robert","year":"1999","journal-title":"Hypertension"},{"key":"2020071613313463000_R12","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1161\/01.CIR.104.2.137","article-title":"Aldosterone induces angiotensin-converting-enzyme gene expression in cultured neonatal rat cardiocytes.","volume":"104","author":"Harada","year":"2001","journal-title":"Circulation"},{"key":"2020071613313463000_R13","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1006\/jmcc.2002.2115","article-title":"Appraisal of the role of angiotensin II and aldosterone in ventricular myocyte apoptosis in adult normotensive rat.","volume":"34","author":"De Angelis","year":"2002","journal-title":"J Mol Cell Cardiol"},{"key":"2020071613313463000_R14","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart.","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"2020071613313463000_R15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-\u03baB activation in angiotensin II-induced cardiac injury.","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"2020071613313463000_R16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.cardiores.2005.03.001","article-title":"Additive amelioration of left ventricular remodeling and molecular alterations by combined aldosterone and angiotensin receptor blockade after myocardial infarction.","volume":"67","author":"Fraccarollo","year":"2005","journal-title":"Cardiovasc Res"},{"key":"2020071613313463000_R17","doi-asserted-by":"crossref","first-page":"H336","DOI":"10.1152\/ajpheart.01307.2005","article-title":"ANG II-induced cardiac molecular and cellular events: role of aldosterone","volume":"291","author":"Zhao","year":"2006","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2020071613313463000_R18","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1096\/fj.05-4642fje","article-title":"Aldosterone mediates angiotensin II-induced interstitial cardiac fibrosis via a Nox2-containing NADPH oxidase.","volume":"20","author":"Johar","year":"2006","journal-title":"FASEB J"},{"key":"2020071613313463000_R19","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1006\/jmcc.1996.0080","article-title":"Angiotensin converting enzyme and myofibroblasts during tissue repair in the rat heart.","volume":"28","author":"Sun","year":"1996","journal-title":"J Mol Cell Cardiol"},{"key":"2020071613313463000_R20","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone.","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"2020071613313463000_R21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJM199909023411001","article-title":"The effect of spironolactone on morbidity and mortality in patients with severe heart failure. Randomized Aldactone Evaluation Study Investigators.","volume":"341","author":"Pitt","year":"1999","journal-title":"N Engl J Med"},{"key":"2020071613313463000_R22","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/S0008-6363(97)00091-6","article-title":"Aldosterone blockade reduces vascular collagen turnover, improves heart rate variability and reduces early morning rise in heart rate in heart failure patients.","volume":"35","author":"MacFadyen","year":"1997","journal-title":"Cardiovasc Res"},{"key":"2020071613313463000_R23","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1161\/01.CIR.99.20.2694","article-title":"Activation of cardiac aldosterone production in rat myocardial infarction: effect of angiotensin II receptor blockade and role in cardiac fibrosis.","volume":"99","author":"Silvestre","year":"1999","journal-title":"Circulation"},{"key":"2020071613313463000_R24","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.bbrc.2003.11.173","article-title":"NAD(P)H oxidase inhibitor prevents blood pressure elevation and cardiovascular hypertrophy in aldosterone-infused rats.","volume":"313","author":"Park","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"2020071613313463000_R25","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload.","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"2020071613313463000_R26","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1161\/01.HYP.0000203148.42892.7a","article-title":"Cardioprotective mechanisms of eplerenone on cardiac performance and remodeling in failing rat hearts.","volume":"47","author":"Kobayashi","year":"2006","journal-title":"Hypertension"},{"key":"2020071613313463000_R27","doi-asserted-by":"crossref","first-page":"F1308","DOI":"10.1152\/ajprenal.00167.2006","article-title":"Oxidative stress and glomerular filtration barrier injury: role of the renin-angiotensin system in the Ren2 transgenic rat","volume":"291","author":"Whaley-Connell","year":"2006","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071613313463000_R28","doi-asserted-by":"crossref","first-page":"F861","DOI":"10.1152\/ajprenal.00252.2006","article-title":"Proximal tubule microvilli remodeling and albuminuria in the Ren2 transgenic rat","volume":"292","author":"Hayden","year":"2007","journal-title":"Am J Physiol Renal Physiol"},{"key":"2020071613313463000_R29","doi-asserted-by":"crossref","first-page":"E353","DOI":"10.1152\/ajpendo.00402.2004","article-title":"Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression","volume":"288","author":"Blendea","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"2020071613313463000_R30","first-page":"807","article-title":"The role of the adrenal gland in hypertensive transgenic rat TGR(mREN2)27.","volume":"131","author":"Sander","year":"1992","journal-title":"Endocrinology"},{"key":"2020071613313463000_R31","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1161\/01.RES.0000099504.30207.F5","article-title":"Contrasting roles of NADPH oxidase isoforms in pressure-overload versus angiotensin II-induced cardiac hypertrophy.","volume":"93","author":"Byrne","year":"2003","journal-title":"Circ Res"},{"key":"2020071613313463000_R32","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1046\/j.1523-1755.2000.00277.x","article-title":"Aldosterone modulates plasminogen activator inhibitor-1 and glomerulosclerosis in vivo.","volume":"58","author":"Brown","year":"2000","journal-title":"Kidney Int"},{"key":"2020071613313463000_R33","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1002\/jmri.20352","article-title":"In vivo assessment of myocardial blood flow in rat heart using magnetic resonance imaging: effect of anesthesia.","volume":"22","author":"Iltis","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"2020071613313463000_R34","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1161\/01.HYP.31.1.451","volume":"31","author":"Rocha","journal-title":"Hypertension"},{"key":"2020071613313463000_R35","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1161\/01.CIR.0000131860.80444.AB","volume":"109","author":"Mazak","journal-title":"Circulation"},{"key":"2020071613313463000_R36","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1161\/hyp.39.2.614","article-title":"Cardiac damage prevention by eplerenone: comparison with low sodium diet or potassium loading.","volume":"39","author":"Martinez","year":"2002","journal-title":"Hypertension"},{"key":"2020071613313463000_R37","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1161\/01.HYP.0000082814.62655.85","article-title":"AT1 blockade prevents glucose-induced cardiac dysfunction in ventricular myocytes: role of the AT1 receptor and NADPH oxidase.","volume":"42","author":"Privratsky","year":"2003","journal-title":"Hypertension"},{"key":"2020071613313463000_R38","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1093\/eurheartj\/5.suppl_F.251","article-title":"The ultrastructure of myocardial hypertrophy: why does the compensated heart fail?","volume":"5","author":"Legato","year":"1984","journal-title":"Eur Heart J"},{"key":"2020071613313463000_R39","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1126\/science.3037703","article-title":"Cloning of human mineralocorticoid receptor complementary DNA: structural and functional kinship with the glucocorticoid receptor.","volume":"237","author":"Arriza","year":"1987","journal-title":"Science"},{"key":"2020071613313463000_R40","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1161\/01.HYP.0000203772.78696.67","article-title":"Mineralocorticoid receptor antagonism attenuates cardiac hypertrophy and failure in low-aldosterone hypertensive rats.","volume":"47","author":"Nagata","year":"2006","journal-title":"Hypertension"},{"key":"2020071613313463000_R41","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/01.mnh.0000133976.32559.b0","article-title":"Glucorticoid- mediated mineralocorticoid receptor activation and hypertension.","volume":"13","author":"Frey","year":"2004","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"2020071613313463000_R42","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1161\/01.HYP.0000032031.30374.32","article-title":"Activation of NADPH oxidase during progression of cardiac hypertrophy to failure.","volume":"40","author":"Li","year":"2002","journal-title":"Hypertension"},{"key":"2020071613313463000_R43","doi-asserted-by":"crossref","first-page":"10121","DOI":"10.1074\/jbc.M112065200","article-title":"Architecture of the p40\u2013p47-p67phox complex in the resting state of the NADPH oxidase. A central role for p67phox.","volume":"277","author":"Lapouge","year":"2002","journal-title":"J Biol Chem"},{"key":"2020071613313463000_R44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.3317\/jraas.2002.004","article-title":"Oxidative stress increases the expression of the angiotensin-II receptor type 1 in mouse peritoneal macrophages.","volume":"3","author":"Keidar","year":"2002","journal-title":"J Renin Angiotensin Aldosterone Syst"}],"container-title":["Endocrinology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/148\/8\/3773\/10725928\/endo3773.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/endo\/article-pdf\/148\/8\/3773\/10725928\/endo3773.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,17]],"date-time":"2020-07-17T00:02:38Z","timestamp":1594944158000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/endo\/article\/148\/8\/3773\/2502118"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,1]]},"references-count":44,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,8,1]]}},"URL":"https:\/\/doi.org\/10.1210\/en.2006-1691","relation":{},"ISSN":["0013-7227","1945-7170"],"issn-type":[{"value":"0013-7227","type":"print"},{"value":"1945-7170","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,1]]}}}